- Home
- PXLW vs ESLA Comparison
PXLW vs ESLA Comparison
Compare PXLW & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PXLW
- ESLA
- Stock Information
- Founded
- PXLW 1997
- ESLA 2021
- Country
- PXLW United States
- ESLA United States
- Employees
- PXLW N/A
- ESLA N/A
- Industry
- PXLW Semiconductors
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PXLW Technology
- ESLA Health Care
- Exchange
- PXLW Nasdaq
- ESLA Nasdaq
- Market Cap
- PXLW 41.8M
- ESLA 41.6M
- IPO Year
- PXLW 2000
- ESLA N/A
- Fundamental
- Price
- PXLW $0.81
- ESLA $0.82
- Analyst Decision
- PXLW Strong Buy
- ESLA
- Analyst Count
- PXLW 3
- ESLA 0
- Target Price
- PXLW $2.17
- ESLA N/A
- AVG Volume (30 Days)
- PXLW 243.1K
- ESLA 15.4K
- Earning Date
- PXLW 11-12-2024
- ESLA 11-19-2024
- Dividend Yield
- PXLW N/A
- ESLA N/A
- EPS Growth
- PXLW N/A
- ESLA N/A
- EPS
- PXLW N/A
- ESLA N/A
- Revenue
- PXLW $54,190,000.00
- ESLA N/A
- Revenue This Year
- PXLW N/A
- ESLA N/A
- Revenue Next Year
- PXLW $32.81
- ESLA N/A
- P/E Ratio
- PXLW N/A
- ESLA N/A
- Revenue Growth
- PXLW N/A
- ESLA N/A
- 52 Week Low
- PXLW $0.61
- ESLA $0.63
- 52 Week High
- PXLW $3.08
- ESLA $3.23
- Technical
- Relative Strength Index (RSI)
- PXLW 59.04
- ESLA 41.94
- Support Level
- PXLW $0.66
- ESLA $0.74
- Resistance Level
- PXLW $0.71
- ESLA $0.84
- Average True Range (ATR)
- PXLW 0.05
- ESLA 0.11
- MACD
- PXLW 0.01
- ESLA 0.01
- Stochastic Oscillator
- PXLW 83.29
- ESLA 37.53
About PXLW Pixelworks Inc.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in China.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.